Trialt and Viedoc Advance Digital Clinical Trial Efficiency
NEEDHAM, Mass., April 3, 2026 Trialt, a global clinical research organization (CRO), has announced a strategic collaboration with Viedoc,...
Technology for New Therapy
Regeneron Partners with TriNetX for 300M Patient Data
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., April 2, 2026 Regeneron Pharmaceuticals, Inc. has announced a strategic collaboration with TriNetX to...
Thermo Fisher Launches Compleo System for Cell Therapy
WALTHAM, Mass., USA — April 2, 2026 Thermo Fisher Scientific Inc. has announced the global launch of the Gibco™...
Philips AI Gains FDA Clearance for Heart Valve Guidance
AMSTERDAM, Netherlands, March 26, 2026 Royal Philips announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
AI Transforms Pharma R&D and Manufacturing Models
London, United Kingdom | March 23, 2026 The pharmaceutical industry is undergoing a profound transformation as artificial intelligence (AI),...
IQVIA Launches AI Platform to Transform Life Sciences
Research Triangle Park, North Carolina, March 16, 2026 IQVIA Holdings Inc. announced the launch of IQVIA.ai, a next-generation unified...
Roche Launches NVIDIA AI Factory for Drug Discovery
Basel, March 16, 2026 Roche announced the launch of a large-scale NVIDIA-powered AI factory, marking a major advancement in...
Tevogen.AI Improves PredicTcell Accuracy for Drug Discovery
WARREN, New Jersey, March 13, 2026 Biotechnology innovator Tevogen Bio Holdings Inc. has announced significant advancements in its Tevogen.AI...
NORD and OpenEvidence Partner for Rare Disease AI
NORWELL, Mass., and MIAMI, Fla., March 12, 2026 The National Organization for Rare Disorders (NORD) and OpenEvidence have announced...
Tempus Study Shows Genomic Profiling Expands Cancer Care
CHICAGO — March 11, 2026 Tempus AI, Inc., a technology company focused on advancing precision medicine through artificial intelligence...